Aclaris Therapeutics (ACRS) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026)
Aclaris Therapeutics (ACRS) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -99.85% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.70% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -79.16% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 10.87% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19.14% |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn | -23.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.50% |
| Mar 31, 2026 | -20.38% |
| Dec 31, 2025 | -24.50% |
| Sep 30, 2025 | -28.42% |
| Jun 30, 2025 | -32.87% |
| Mar 31, 2025 | -38.47% |
| Dec 31, 2024 | -37.78% |
| Sep 30, 2024 | -35.77% |
| Jun 30, 2024 | -31.91% |
| Mar 31, 2024 | 1.19% |
| Dec 31, 2023 | 47.41% |
| Sep 30, 2023 | 54.06% |
| Jun 30, 2023 | 48.82% |
| Mar 31, 2023 | 18.48% |
| Dec 31, 2022 | -17.68% |
| Sep 30, 2022 | -2.14% |
| Jun 30, 2022 | -0.85% |
| Mar 31, 2022 | -10.32% |
| Dec 31, 2021 | -19.29% |
| Sep 30, 2021 | -39.06% |